China SXT Pharmaceuticals, Inc. Quarterly Liabilities, Current in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
China SXT Pharmaceuticals, Inc. quarterly Liabilities, Current history and growth rate from Q1 2018 to Q3 2024.
  • China SXT Pharmaceuticals, Inc. Liabilities, Current for the quarter ending September 30, 2024 was $15.7M, a 70.3% increase year-over-year.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $15.7M +$6.46M +70.3% Sep 30, 2024 6-K 2025-03-28
Q1 2024 $8.9M -$5.59M -38.6% Mar 31, 2024 6-K 2025-03-28
Q3 2023 $9.2M +$1.91M +26.2% Sep 30, 2023 6-K 2024-04-05
Q1 2023 $14.5M -$2.62M -15.3% Mar 31, 2023 20-F 2024-08-13
Q3 2022 $7.29M -$1.59M -17.9% Sep 30, 2022 6-K 2023-02-24
Q1 2022 $17.1M -$1.46M -7.85% Mar 31, 2022 20-F 2023-07-31
Q3 2021 $8.88M +$3.37M +61.2% Sep 30, 2021 6-K 2022-01-14
Q1 2021 $18.6M +$6.32M +51.5% Mar 31, 2021 20-F/A 2023-05-19
Q3 2020 $5.51M -$5.26M -48.8% Sep 30, 2020 6-K 2021-01-28
Q1 2020 $12.3M +$5.94M +94% Mar 31, 2020 20-F 2021-08-13
Q3 2019 $10.8M Sep 30, 2019 6-K/A 2020-05-22
Q1 2019 $6.32M +$1.95M +44.6% Mar 31, 2019 20-F 2020-07-31
Q1 2018 $4.37M Mar 31, 2018 20-F 2019-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.